小规模模型用于预测生物治疗中运输诱导的颗粒形成
Urška Pečarič Strnad1, Petra Zalokar1, Natan Osterman2
1Biologics Drug Product, Technical Research and Development, Global Drug Development, Novartis, Kolodvorska 27, Mengeš, Slovenia.
Colloids and surfaces. B, Biointerfaces
|October 12, 2024
概括
在空气液体接口的蛋白质聚合是一个挑战. 这项研究表明,吸附率和表面膜动态预测粒子形成,有助于生物制药稳定性研究.
科学领域:
- 生物物理化学 生物物理化学
- 体科学 体科学 体科学
- 生物制药科学 生物制药科学
背景情况:
- 蛋白质在空气液体接口上吸附和展开,形成粘弹性薄膜.
- 表面动可以破坏这些膜,导致不良的蛋白质聚合.
- 蛋白质聚合物存在风险,特别是在生物制药应用中.
研究的目的:
- 为了预测生物制药溶液中的表面介导蛋白质聚合.
- 了解吸附动态对蛋白质溶液稳定性的影响.
- 开发改进的生物制药稳定性研究,模拟运输条件.
主要方法:
- 布鲁斯特角显微镜用于研究界面膜.
- 微流成像,光散射和尺寸排除色谱用于聚合监测.
- 吸附率与表面周转率的分析.
主要成果:
- 蛋白质颗粒的形成是由吸附率与表面周转率的比率驱动的.
- 在静止阶段的表面膜动态直接影响聚合.
- 在空气-液体界面的吸附动态显著影响蛋白质溶液的稳定性.
结论:
- 预测蛋白质聚合对于生物制药的处理和稳定性至关重要.
- 了解界面动力学,可以了解体和生物系统.
- 学习可以为新型,小型生物制药稳定性研究的设计提供信息.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
33
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
33
Pharmacokinetic Models: Comparison and Selection Criterion
47
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
47
Pharmacokinetic Models: Overview
603
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
603
Physiological Pharmacokinetic Models: Assumption with Protein Binding
35
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
35
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
62
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
62
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
69
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
69


